Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by KBC Group NV

KBC Group NV lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 49.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 225,371 shares of the company's stock after selling 219,241 shares during the quarter. KBC Group NV owned about 0.18% of Henry Schein worth $16,429,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Henry Schein by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company's stock valued at $1,165,425,000 after acquiring an additional 260,537 shares during the last quarter. American Century Companies Inc. lifted its holdings in Henry Schein by 3.1% in the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock worth $351,543,000 after buying an additional 162,477 shares during the period. Swedbank AB purchased a new stake in Henry Schein in the first quarter worth $215,998,000. Nuance Investments LLC grew its stake in shares of Henry Schein by 6.2% in the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company's stock worth $119,440,000 after buying an additional 108,143 shares during the last quarter. Finally, Burgundy Asset Management Ltd. raised its holdings in Henry Schein by 1.0% in the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock worth $105,148,000 after buying an additional 16,476 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Up 3.3 %

HSIC traded up $2.22 during midday trading on Friday, hitting $68.76. 2,510,286 shares of the company were exchanged, compared to its average volume of 1,358,096. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm's 50 day moving average price is $70.30 and its 200-day moving average price is $69.57. The firm has a market capitalization of $8.57 billion, a P/E ratio of 28.30, a P/E/G ratio of 1.94 and a beta of 0.87. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's quarterly revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Robert W. Baird dropped their price objective on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a report on Wednesday, August 7th. UBS Group lowered their price target on Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 7th. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, Baird R W upgraded Henry Schein from a "hold" rating to a "strong-buy" rating in a report on Monday, July 22nd. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Henry Schein currently has an average rating of "Moderate Buy" and an average price target of $78.89.

Insider Activity

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.